System Transmission

Top Signal

100#1 JOB

Activity

2171Ripe

+912 today

System

Livenow

Terminal Asset View

stockNASDAQ

KROS

$11.02+0.27%

Keros Therapeutics Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

20Neutral

Live Analysis Active

Company Mission

Keros Therapeutics is a biotechnology company that creates experimental medicines for blood disorders and muscle diseases. They develop these drugs through scientific research and clinical testing, hoping to get approval from health regulators. The company makes money primarily from research grants, partnerships with larger pharmaceutical companies, and investor funding that supports their drug development programs until they can potentially bring treatments to market.

KRO

Industry Context

Biotechnology companies develop new medical treatments through scientific research. This industry experiences significant price swings based on clinical trial results, regulatory approvals, and investor sentiment about potential new drugs.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

25Matrix

Market Momentum

17.5— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.1x— Normal Volume

Today's Change

0.27%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-1

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing KROS across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 03:45 AM UTC

As-of 03-15-2026 03:30 UTC

Develops drugs that treat blood disorders and makes money by selling these treatments to hospitals and clinics.

Price dropped too fast and might bounce from oversold conditions, suggesting potential short-term recovery near recent lows.

Biotech sector showing volatility as FDA decisions approach, creating opportunities for companies with promising late-stage drug candidates,.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...